James V Jester1, Naoyuki Morishige, Lbachir BenMohamed, Donald J Brown, Nelson Osorio, Chinhui Hsiang, Guey Chuen Perng, Clinton Jones, Steven L Wechsler. 1. *Gavin Herbert Eye Institute, University of California Irvine, School of Medicine, Irvine, CA; †Department of Biomedical Engineering, University of Irvine, Irvine; ‡Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan; §Cellular and Molecular Immunology Laboratory, University of California Irvine, Irvine, CA ¶Institute for Immunology, University of California Irvine, Irvine, CA ‖Department of Microbiology and Immunology, National Cheng Kung University, Tainan Taiwan; **School of Veterinary Medicine and Biomedical Sciences, Nebraska Center for Virology, University of Nebraska, Lincoln, NE; ††Department of Microbiology and Molecular Genetics, University of California Irvine, School of Medicine, Irvine, CA; and ‡‡The Center for Virus Research, University of California, Irvine, Irvine, CA.
Abstract
PURPOSE: Using CJLAT, a chimeric herpes simplex virus (HSV-1) that produces a high incidence of herpes stromal keratitis (HSK) in latently infected rabbits, and in vivo confocal microscopy (CM), we characterized the cellular events that precede the development of HSK. METHODS: Thirty days after infection, in vivo CM was performed daily for 10 days and then weekly for up to 80 days after infection. RESULTS: We detected 3 types of subclinical corneal lesions before HSK was clinically apparent: (1) small epithelial erosions; (2) regenerating epithelium overlying small cell infiltrates within the basal epithelial cell layer; and (3) dendritic-like cells within the basal epithelial layer overlying stromal foci containing infiltrating cells. Sequential in vivo CM observations suggested that subclinical foci resolved over time but were larger and more abundant with CJLAT than with wild-type HSV-1 McKrae. Active HSK was observed only with CJLAT and was initially associated with a large epithelial lesion overlying stromal immune cell infiltrates. CONCLUSIONS: These results suggest that replication in the cornea of reactivated virus from the trigeminal ganglia produces epithelial lesions, which recruit immune cell infiltrates into the basal epithelial layer and anterior stroma. The virus is usually cleared rapidly eliminating viral antigens before the arrival of the immune cells, which disperse. However, if the virus is not cleared rapidly, or if an additional reactivation results in an additional round of virus at the same site before the immune cells disperse, then the immune cells are stimulated and may induce an immunopathological response leading to the development of HSK.
PURPOSE: Using CJLAT, a chimeric herpes simplex virus (HSV-1) that produces a high incidence of herpes stromal keratitis (HSK) in latently infected rabbits, and in vivo confocal microscopy (CM), we characterized the cellular events that precede the development of HSK. METHODS: Thirty days after infection, in vivo CM was performed daily for 10 days and then weekly for up to 80 days after infection. RESULTS: We detected 3 types of subclinical corneal lesions before HSK was clinically apparent: (1) small epithelial erosions; (2) regenerating epithelium overlying small cell infiltrates within the basal epithelial cell layer; and (3) dendritic-like cells within the basal epithelial layer overlying stromal foci containing infiltrating cells. Sequential in vivo CM observations suggested that subclinical foci resolved over time but were larger and more abundant with CJLAT than with wild-type HSV-1 McKrae. Active HSK was observed only with CJLAT and was initially associated with a large epithelial lesion overlying stromal immune cell infiltrates. CONCLUSIONS: These results suggest that replication in the cornea of reactivated virus from the trigeminal ganglia produces epithelial lesions, which recruit immune cell infiltrates into the basal epithelial layer and anterior stroma. The virus is usually cleared rapidly eliminating viral antigens before the arrival of the immune cells, which disperse. However, if the virus is not cleared rapidly, or if an additional reactivation results in an additional round of virus at the same site before the immune cells disperse, then the immune cells are stimulated and may induce an immunopathological response leading to the development of HSK.
Authors: Katarina Polcicova; Partha Sarathi Biswas; Kaustuv Banerjee; Todd W Wisner; Barry T Rouse; David C Johnson Journal: Proc Natl Acad Sci U S A Date: 2005-07-29 Impact factor: 11.205
Authors: Arif A Khan; Ruchi Srivastava; Hawa Vahed; Soumyabrata Roy; Sager S Walia; Grace J Kim; Mona A Fouladi; Taikun Yamada; Vincent T Ly; Cynthia Lam; Anthony Lou; Vivianna Nguyen; Undariya Boldbaatar; Roger Geertsema; Nigel W Fraser; Lbachir BenMohamed Journal: J Virol Date: 2018-07-31 Impact factor: 5.103
Authors: Ruchi Srivastava; Xavier Dervillez; Arif A Khan; Aziz A Chentoufi; Sravya Chilukuri; Nora Shukr; Yasmin Fazli; Nicolas N Ong; Rasha E Afifi; Nelson Osorio; Roger Geertsema; Anthony B Nesburn; Steven L Wechsler; Lbachir BenMohamed Journal: J Virol Date: 2016-03-28 Impact factor: 5.103
Authors: Pedro J Esteves; Joana Abrantes; Hanna-Mari Baldauf; Lbachir BenMohamed; Yuxing Chen; Neil Christensen; Javier González-Gallego; Lorenzo Giacani; Jiafen Hu; Gilla Kaplan; Oliver T Keppler; Katherine L Knight; Xiang-Peng Kong; Dennis K Lanning; Jacques Le Pendu; Ana Lemos de Matos; Jia Liu; Shuying Liu; Ana M Lopes; Shan Lu; Sheila Lukehart; Yukari C Manabe; Fabiana Neves; Grant McFadden; Ruimin Pan; Xuwen Peng; Patricia de Sousa-Pereira; Ana Pinheiro; Masmudur Rahman; Natalie Ruvoën-Clouet; Selvakumar Subbian; Maria Jesús Tuñón; Wessel van der Loo; Michael Vaine; Laura E Via; Shixia Wang; Rose Mage Journal: Exp Mol Med Date: 2018-05-22 Impact factor: 8.718
Authors: Pierre-Gregoire Coulon; Nisha Dhanushkodi; Swayam Prakash; Ruchi Srivastava; Soumyabrata Roy; Nuha I Alomari; Angela M Nguyen; Wasay R Warsi; Caitlin Ye; Edgar A Carlos-Cruz; Uyen T Mai; Audrey C Cruel; Keysi M Ekmekciyan; Eric Pearlman; Lbachir BenMohamed Journal: Front Immunol Date: 2019-07-16 Impact factor: 8.786